首页 > 最新文献

Frontiers in medical technology最新文献

英文 中文
Extracellular vesicle signatures from eye lavage as novel non-invasive biomarkers for hypoxic ischaemic insult-findings from a neonatal mouse model. 眼灌洗的细胞外囊泡特征作为缺氧缺血性损伤的新型非侵入性生物标志物——来自新生小鼠模型的发现。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-12-18 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1715676
Runci Li, Sarah R Needham, Igor Kraev, Mariya Hristova, Sigrun Lange

Neonatal hypoxia ischaemia (HI) affects 1-3 per 1,000 live births, is a major cause of infant mortality and morbidity, and leads to adverse long-term neurological outcomes, while reliable biomarkers are scarce. Extracellular vesicles (EVs) are small membrane vesicles released from cells and play key roles in cellular communication through the transfer of diverse cargoes, including proteins, and can be isolated from various body fluids. Here, we developed a new non-invasive method of biofluid-EV profiling, isolating EVs from eye lavage. Our data demonstrate that in a neonatal HI mouse model of mild and severe insults, significant differences are found in EV eye lavage signatures. We identified increased EV numbers and modifications in EV size profiles and EV's proteomic cargo signatures in eye lavage from HI animals compared to controls. A protein-protein interaction network analysis of the EV proteome cargoes identified enrichment in Gene Ontology and Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathways in the HI groups associated with various homeostatic and disease-related pathways. The specific changes in the mild HI group included pathways for ribosome biogenesis, translation, RNA processing, gene expression, blood coagulation, innate immunity, antioxidant activity, phospholipid binding, post-synapse, cell cortex, and HIF-1 signalling. The enriched pathways only associated with the EV proteome of the severe HI group included cytoskeleton organisation, peptide cross-linking, monosaccharide biosynthesis, peroxidase activity, extrinsic component of plasma membrane, the GAIT complex, mast cell granulation, ruffle, and sealing of the nuclear envelope by the endosomal sorting complex required for transport III. Here, we report a new non-invasive method using eye lavage EV signatures to identify changes in response to HI. Our results highlight eye lavage EVs as potential clinical biomarkers for predicting changes that occur in the brain and eye due to different neonatal HI injury severities.

新生儿缺氧缺血性(HI)影响1-3 / 1000活产婴儿,是婴儿死亡率和发病率的主要原因,并导致不良的长期神经系统预后,而可靠的生物标志物很少。细胞外囊泡(EVs)是从细胞中释放出来的小膜囊泡,在细胞通信中发挥关键作用,通过多种货物(包括蛋白质)的转移,可以从各种体液中分离出来。在此,我们开发了一种新的非侵入性生物流体- ev分析方法,从眼灌洗液中分离ev。我们的数据表明,在轻度和重度损伤的新生儿HI小鼠模型中,EV洗眼信号存在显著差异。我们发现,与对照组相比,在HI动物的眼睛冲洗中,EV数量增加,EV大小谱和EV蛋白质组学特征发生了变化。对EV蛋白质组的蛋白质相互作用网络分析发现,在HI组中,与各种稳态和疾病相关途径相关的基因本体和京都基因与基因组百科全书(KEGG)途径中富集。轻度HI组的特异性变化包括核糖体生物发生、翻译、RNA加工、基因表达、血液凝固、先天免疫、抗氧化活性、磷脂结合、突触后、细胞皮层和HIF-1信号传导途径。仅与严重HI组EV蛋白质组相关的富集途径包括细胞骨架组织、肽交联、单糖生物合成、过氧化物酶活性、质膜的外部成分、步态复合物、肥大细胞肉芽化、褶皱以及运输所需的内体分选复合物对核膜的密封III。在这里,我们报告了一种新的非侵入性方法,使用眼灌洗EV特征来识别HI反应的变化。我们的研究结果强调了眼灌洗EVs作为潜在的临床生物标志物,可以预测不同新生儿HI损伤严重程度导致的大脑和眼睛变化。
{"title":"Extracellular vesicle signatures from eye lavage as novel non-invasive biomarkers for hypoxic ischaemic insult-findings from a neonatal mouse model.","authors":"Runci Li, Sarah R Needham, Igor Kraev, Mariya Hristova, Sigrun Lange","doi":"10.3389/fmedt.2025.1715676","DOIUrl":"10.3389/fmedt.2025.1715676","url":null,"abstract":"<p><p>Neonatal hypoxia ischaemia (HI) affects 1-3 per 1,000 live births, is a major cause of infant mortality and morbidity, and leads to adverse long-term neurological outcomes, while reliable biomarkers are scarce. Extracellular vesicles (EVs) are small membrane vesicles released from cells and play key roles in cellular communication through the transfer of diverse cargoes, including proteins, and can be isolated from various body fluids. Here, we developed a new non-invasive method of biofluid-EV profiling, isolating EVs from eye lavage. Our data demonstrate that in a neonatal HI mouse model of mild and severe insults, significant differences are found in EV eye lavage signatures. We identified increased EV numbers and modifications in EV size profiles and EV's proteomic cargo signatures in eye lavage from HI animals compared to controls. A protein-protein interaction network analysis of the EV proteome cargoes identified enrichment in Gene Ontology and Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathways in the HI groups associated with various homeostatic and disease-related pathways. The specific changes in the mild HI group included pathways for ribosome biogenesis, translation, RNA processing, gene expression, blood coagulation, innate immunity, antioxidant activity, phospholipid binding, post-synapse, cell cortex, and HIF-1 signalling. The enriched pathways only associated with the EV proteome of the severe HI group included cytoskeleton organisation, peptide cross-linking, monosaccharide biosynthesis, peroxidase activity, extrinsic component of plasma membrane, the GAIT complex, mast cell granulation, ruffle, and sealing of the nuclear envelope by the endosomal sorting complex required for transport III. Here, we report a new non-invasive method using eye lavage EV signatures to identify changes in response to HI. Our results highlight eye lavage EVs as potential clinical biomarkers for predicting changes that occur in the brain and eye due to different neonatal HI injury severities.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1715676"},"PeriodicalIF":3.8,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12756510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145901978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FE-based risk assessment of coronary artery compression in pulmonary conduit pre-stenting: optimizing the balance between time-expense and reliability. 基于fe的肺动脉支架预植入术冠状动脉压迫风险评估:优化时间费用与可靠性之间的平衡。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-12-18 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1686131
Davide Astori, Francesco Sturla, Alessandro Caimi, Francesco Secchi, Luca Giugno, Alberto Redaelli, Mario Carminati, Emiliano Votta

Background and objective: Calcific obstruction of the pulmonary conduit is a late complication of surgical implantation of a homograft in congenital patients. Percutaneous pulmonary valve implantation (PPVI) is an effective alternative to surgical repair. However, this procedure is affected by several complications, with coronary artery (CA) compression being one of the most severe. High-fidelity finite element (FE) models can provide accurate predictions but are too computationally expensive for routine use, whereas simplified models sacrifice mechanical fidelity. This study proposes a novel FE-based framework to investigate conduit pre-stenting feasibility, while aiming to balance computational efficiency with predictive accuracy within clinically relevant timelines.

Methods: A semi-automated pipeline was developed, requiring manual input only for the segmentation of computed tomography (CT), virtual stent positioning, and simulation launch. Patient-specific geometries were meshed and processed through an automated in-house script, generating ready-to-run Abaqus input files. A multifactorial CA compression risk index was introduced, integrating baseline and post-expansion distances between the pulmonary artery and CA, and their changes during the procedure. The FE simulation of the pre-stenting procedure was tested on 10 PPVI candidates, simulating CP-stent implantation. Simulation accuracy was assessed against fluoroscopy-derived stent diameters.

Results: The full simulation process required less than 10 h per case, with minimal operator workload. FE-predicted stent configuration showed strong agreement with fluoroscopic measurements ( R 2 = 0.87), with a mean absolute error of 3.5 ± 4.4%. Accuracy was highest in patients with calcific volumes <0.8  cm 3 (error <0.5 mm). CA compression index identified 2 high-risk, 2 moderate-risk, and 6 negligible-risk patients. Peri-procedural fluoroscopy was not available for one negligible-risk patient; it excluded CA compression for the remaining negligible-risk patients (true negatives), for all moderate-risk patients, and for one high-risk patient (false positive); it highlighted CA compression for the remaining high-risk patient (true positive).

Conclusions: The proposed FE simulation framework enables patient-specific prediction of stent configuration and CA compression risk within clinically compatible timelines. The balanced trade-off between mechanical fidelity and computational efficiency supports its potential integration into pre-procedural planning of conduit pre-stenting and PPVI.

背景与目的:肺导管钙化性梗阻是先天性同种异体移植物植入术的晚期并发症。经皮肺动脉瓣植入术(PPVI)是手术修复的有效选择。然而,该手术受到几种并发症的影响,冠状动脉(CA)压迫是最严重的并发症之一。高保真有限元(FE)模型可以提供准确的预测,但对于日常使用来说计算成本太高,而简化模型则牺牲了机械保真度。本研究提出了一种新的基于fe的框架来研究导管预支架置入的可行性,同时旨在平衡计算效率和临床相关时间内的预测准确性。方法:开发了半自动化流水线,仅需要人工输入计算机断层扫描(CT)分割、虚拟支架定位和模拟发射。特定于患者的几何图形通过自动化的内部脚本进行网格化和处理,生成随时可以运行的Abaqus输入文件。引入多因素CA压缩风险指数,综合基线和扩张后肺动脉与CA之间的距离及其在手术过程中的变化。对10例PPVI候选者进行预支架植入过程的有限元模拟,模拟cp -支架植入。模拟的准确性根据透视得出的支架直径进行评估。结果:整个模拟过程每个病例需要不到10小时,操作人员的工作量最小。fe预测的支架形态与透视测量结果非常吻合(r2 = 0.87),平均绝对误差为3.5±4.4%。结论:提出的FE模拟框架能够在临床相容的时间线内对患者特异性的支架配置和CA压缩风险进行预测。机械保真度和计算效率之间的平衡平衡支持其潜在的整合到管道预支架植入和PPVI的术前规划中。
{"title":"FE-based risk assessment of coronary artery compression in pulmonary conduit pre-stenting: optimizing the balance between time-expense and reliability.","authors":"Davide Astori, Francesco Sturla, Alessandro Caimi, Francesco Secchi, Luca Giugno, Alberto Redaelli, Mario Carminati, Emiliano Votta","doi":"10.3389/fmedt.2025.1686131","DOIUrl":"10.3389/fmedt.2025.1686131","url":null,"abstract":"<p><strong>Background and objective: </strong>Calcific obstruction of the pulmonary conduit is a late complication of surgical implantation of a homograft in congenital patients. Percutaneous pulmonary valve implantation (PPVI) is an effective alternative to surgical repair. However, this procedure is affected by several complications, with coronary artery (CA) compression being one of the most severe. High-fidelity finite element (FE) models can provide accurate predictions but are too computationally expensive for routine use, whereas simplified models sacrifice mechanical fidelity. This study proposes a novel FE-based framework to investigate conduit pre-stenting feasibility, while aiming to balance computational efficiency with predictive accuracy within clinically relevant timelines.</p><p><strong>Methods: </strong>A semi-automated pipeline was developed, requiring manual input only for the segmentation of computed tomography (CT), virtual stent positioning, and simulation launch. Patient-specific geometries were meshed and processed through an automated <i>in-house</i> script, generating ready-to-run Abaqus input files. A multifactorial CA compression risk index was introduced, integrating baseline and post-expansion distances between the pulmonary artery and CA, and their changes during the procedure. The FE simulation of the pre-stenting procedure was tested on 10 PPVI candidates, simulating CP-stent implantation. Simulation accuracy was assessed against fluoroscopy-derived stent diameters.</p><p><strong>Results: </strong>The full simulation process required less than 10 h per case, with minimal operator workload. FE-predicted stent configuration showed strong agreement with fluoroscopic measurements ( <math><msup><mi>R</mi> <mn>2</mn></msup> </math> = 0.87), with a mean absolute error of 3.5 <math><mo>±</mo></math> 4.4%. Accuracy was highest in patients with calcific volumes <0.8  <math> <msup><mrow><mi>cm</mi></mrow> <mn>3</mn></msup> </math> (error <0.5 mm). CA compression index identified 2 high-risk, 2 moderate-risk, and 6 negligible-risk patients. Peri-procedural fluoroscopy was not available for one negligible-risk patient; it excluded CA compression for the remaining negligible-risk patients (true negatives), for all moderate-risk patients, and for one high-risk patient (false positive); it highlighted CA compression for the remaining high-risk patient (true positive).</p><p><strong>Conclusions: </strong>The proposed FE simulation framework enables patient-specific prediction of stent configuration and CA compression risk within clinically compatible timelines. The balanced trade-off between mechanical fidelity and computational efficiency supports its potential integration into pre-procedural planning of conduit pre-stenting and PPVI.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1686131"},"PeriodicalIF":3.8,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12756087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145902022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Microbial therapeutics: harnessing the human microbiome for disease treatment and prevention. 社论:微生物疗法:利用人类微生物组进行疾病治疗和预防。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-12-12 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1751147
Ali Asger Bhojiya, Abhinav Saurabh, Devendra Jain
{"title":"Editorial: Microbial therapeutics: harnessing the human microbiome for disease treatment and prevention.","authors":"Ali Asger Bhojiya, Abhinav Saurabh, Devendra Jain","doi":"10.3389/fmedt.2025.1751147","DOIUrl":"https://doi.org/10.3389/fmedt.2025.1751147","url":null,"abstract":"","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1751147"},"PeriodicalIF":3.8,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741119/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145852017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An innovative automatic feeding device for preterm infants: promoting the development of sucking ability. 一种创新的早产儿自动喂养装置:促进吸吮能力的发展。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-12-09 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1691199
Fei Luo, Xiaoli Zhao, Yi Lin, Huiling Huang, Zinan Liu, Junhong Xu, Hongping Li

Preterm infants, particularly those born before 32 weeks of gestation, frequently face challenges in achieving full enteral nutrition due to underdeveloped sucking-swallowing-breathing coordination. Conventional feeding methods, such as the use of indwelling nasogastric tubes, overlook the importance of sucking activity, which is essential for the development of gastrointestinal motility and the secretion of digestive enzymes. To address this issue, we have developed a sucking-rewarded automatic feeding device specifically designed for preterm infants. The device features a specialized pacifier that detects sucking activity and triggers the delivery of a predetermined amount of milk into the stomach via a gastric tube. In addition to promoting sucking-induced satiety, the device continuously monitors sucking waveforms to assess infants' viability and sucking maturity. In a clinical pilot study involving 25 preterm infants, those fed with the device demonstrated a significant increase in intestinal oxygen saturation compared with conventional gavage feeding (p < 0.05). Complementary experiments in 12 newborn beagle puppies showed faster gastric emptying rates (p < 0.01) and elevated gastrointestinal hormone levels (p < 0.05) when using the device. These findings highlight the clinical potential of the proposed device in improving feeding safety, efficiency, and developmental outcomes in preterm infants, and warrant further large-scale clinical trials to validate its long-term efficacy and integration into neonatal care.

早产儿,特别是在妊娠32周之前出生的早产儿,由于吮吸-吞咽-呼吸协调不发达,经常面临实现充分肠内营养的挑战。传统的喂养方法,如使用鼻胃管留置,忽视了吸吮活动的重要性,吸吮活动对于胃肠运动的发展和消化酶的分泌至关重要。为了解决这一问题,我们开发了一种专门为早产儿设计的吸吮奖励自动喂养装置。该设备的特点是一个专门的安抚奶嘴,可以检测到吸吮活动,并触发通过胃管将预定数量的牛奶输送到胃中。除了促进吮吸诱导的饱腹感外,该设备还持续监测吮吸波形,以评估婴儿的生存能力和吮吸成熟度。在一项涉及25名早产儿的临床初步研究中,与常规灌胃喂养相比,使用该设备喂养的早产儿肠道氧饱和度显著增加
{"title":"An innovative automatic feeding device for preterm infants: promoting the development of sucking ability.","authors":"Fei Luo, Xiaoli Zhao, Yi Lin, Huiling Huang, Zinan Liu, Junhong Xu, Hongping Li","doi":"10.3389/fmedt.2025.1691199","DOIUrl":"10.3389/fmedt.2025.1691199","url":null,"abstract":"<p><p>Preterm infants, particularly those born before 32 weeks of gestation, frequently face challenges in achieving full enteral nutrition due to underdeveloped sucking-swallowing-breathing coordination. Conventional feeding methods, such as the use of indwelling nasogastric tubes, overlook the importance of sucking activity, which is essential for the development of gastrointestinal motility and the secretion of digestive enzymes. To address this issue, we have developed a sucking-rewarded automatic feeding device specifically designed for preterm infants. The device features a specialized pacifier that detects sucking activity and triggers the delivery of a predetermined amount of milk into the stomach via a gastric tube. In addition to promoting sucking-induced satiety, the device continuously monitors sucking waveforms to assess infants' viability and sucking maturity. In a clinical pilot study involving 25 preterm infants, those fed with the device demonstrated a significant increase in intestinal oxygen saturation compared with conventional gavage feeding (<i>p</i> < 0.05). Complementary experiments in 12 newborn beagle puppies showed faster gastric emptying rates (<i>p</i> < 0.01) and elevated gastrointestinal hormone levels (<i>p</i> < 0.05) when using the device. These findings highlight the clinical potential of the proposed device in improving feeding safety, efficiency, and developmental outcomes in preterm infants, and warrant further large-scale clinical trials to validate its long-term efficacy and integration into neonatal care.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1691199"},"PeriodicalIF":3.8,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12722832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145829457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frailty is associated with low physical activity and poor sleep quality in patients undergoing myeloablative allogeneic hematopoietic cell transplantation: a Fitbit® pilot study. Fitbit®的一项初步研究表明,接受清髓异基因造血细胞移植的患者身体虚弱与低体力活动和睡眠质量差有关。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-12-08 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1605164
Caryn R Libbert, Fiona He, Najla El Jurdi, Helen Fagrelius, Mark Juckett, Joseph Maakaron, William Juckett, Nicholas Evanoff, Donald R Dengel, Shernan G Holtan

Introduction: Frailty, a multidimensional syndrome of reduced physiologic reserve, is associated with poorer outcomes following allogeneic hematopoietic cell transplantation (alloHCT), even among younger adults. This pilot study explores whether wearable sensor data reflecting physical activity and sleep are associated with pre-transplant frailty status in patients undergoing myeloablative alloHCT.

Methods: Adults undergoing first myeloablative alloHCT at the University of Minnesota from June 2022 to January 2023 were enrolled and given Fitbit® Sense devices. Frailty was assessed pre-transplant using Fried Phenotype criteria. Activity and sleep data were collected from hospital admission to day +30 post-transplant. Descriptive and inferential statistics assessed differences across frailty phenotypes.

Results: Nine patients were included: 2 not frail, 5 pre-frail, and 2 frail. Not frail patients demonstrated significantly higher daily steps and active minutes, and lower sedentary time compared to pre-frail and frail groups (all p < 0.01). Frail individuals had significantly reduced deep and REM sleep. The nadir for sleep and peak in sedentary behavior occurred around day +15 post-transplant.

Conclusion: Pre-transplant frailty was associated with decreased physical activity and less restorative sleep during the peri-transplant period. These findings support further study of wearable data to guide personalized supportive care strategies in alloHCT recipients.

虚弱是一种生理储备减少的多维综合征,与异体造血细胞移植(allogenic hematopoietic cell transplantation, alloHCT)后较差的预后相关,甚至在年轻人中也是如此。这项初步研究探讨了反映身体活动和睡眠的可穿戴传感器数据是否与接受骨髓清除异体hct患者移植前的虚弱状态有关。方法:从2022年6月至2023年1月,在明尼苏达大学接受首次骨髓清除异体hct的成人入组并给予Fitbit®Sense设备。移植前使用Fried表型标准评估脆弱性。从入院到移植后第30天收集活动和睡眠数据。描述性和推断性统计评估了脆弱表型之间的差异。结果:纳入9例患者:未体弱2例,体弱前期5例,体弱2例。与体弱多病组和体弱多病组相比,非体弱多病患者表现出更高的每日步数和活动分钟数,以及更少的久坐时间(均为p)。结论:移植前体弱多病与移植前后身体活动减少和恢复性睡眠减少有关。这些发现支持可穿戴数据的进一步研究,以指导异体hct接受者的个性化支持护理策略。
{"title":"Frailty is associated with low physical activity and poor sleep quality in patients undergoing myeloablative allogeneic hematopoietic cell transplantation: a Fitbit® pilot study.","authors":"Caryn R Libbert, Fiona He, Najla El Jurdi, Helen Fagrelius, Mark Juckett, Joseph Maakaron, William Juckett, Nicholas Evanoff, Donald R Dengel, Shernan G Holtan","doi":"10.3389/fmedt.2025.1605164","DOIUrl":"10.3389/fmedt.2025.1605164","url":null,"abstract":"<p><strong>Introduction: </strong>Frailty, a multidimensional syndrome of reduced physiologic reserve, is associated with poorer outcomes following allogeneic hematopoietic cell transplantation (alloHCT), even among younger adults. This pilot study explores whether wearable sensor data reflecting physical activity and sleep are associated with pre-transplant frailty status in patients undergoing myeloablative alloHCT.</p><p><strong>Methods: </strong>Adults undergoing first myeloablative alloHCT at the University of Minnesota from June 2022 to January 2023 were enrolled and given Fitbit® Sense devices. Frailty was assessed pre-transplant using Fried Phenotype criteria. Activity and sleep data were collected from hospital admission to day +30 post-transplant. Descriptive and inferential statistics assessed differences across frailty phenotypes.</p><p><strong>Results: </strong>Nine patients were included: 2 not frail, 5 pre-frail, and 2 frail. Not frail patients demonstrated significantly higher daily steps and active minutes, and lower sedentary time compared to pre-frail and frail groups (all <i>p</i> < 0.01). Frail individuals had significantly reduced deep and REM sleep. The nadir for sleep and peak in sedentary behavior occurred around day +15 post-transplant.</p><p><strong>Conclusion: </strong>Pre-transplant frailty was associated with decreased physical activity and less restorative sleep during the peri-transplant period. These findings support further study of wearable data to guide personalized supportive care strategies in alloHCT recipients.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1605164"},"PeriodicalIF":3.8,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12719429/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145822480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Explainable machine learning for predicting postoperative length of stay after gastrectomy: a nationwide study using XGBoost and SHAP. 可解释的机器学习预测胃切除术后术后住院时间:一项使用XGBoost和SHAP的全国性研究。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-12-05 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1732580
Tsunehiko Maruyama, Kazuto Ikezawa, Hideo Suzuki, Tomohiro Kurokawa, Yoshimasa Akashi, Tatsuya Oda

Background: Gastric cancer remains a major cause of cancer-related morbidity and mortality. Despite advances in surgical and perioperative care, prolonged hospitalization continues to strain healthcare systems. Predicting postoperative length of stay (LOS) could support personalized care and efficient resource allocation. Japan's nationwide Diagnosis Procedure Combination (DPC) database provides real-world data for large-scale analysis, but no study has applied machine learning to predict LOS after gastrectomy.

Methods: This retrospective study included 26,097 patients who underwent gastrectomy between 2017 and 2022 at 472 hospitals in Japan. Using XGBoost, we developed a predictive model based on 1,433 admission-time variables extracted from the DPC database. Model performance was evaluated using Root Mean Squared Error (RMSE) and Mean Absolute Error (MAE) in a five-fold cross-validation. SHAP values were used to interpret feature importance.

Results: The final model achieved an RMSE of 3.74 and MAE of 2.82 days. Key predictors of LOS included surgical procedure (laparoscopic distal gastrectomy and open total gastrectomy), designated cancer hospital, hospital size, peritoneal dissemination, and admission ADL score. SHAP analysis revealed that Laparoscopic distal gastrectomy and higher hospital volume were associated with shorter LOS, while open total gastrectomy was associated with longer LOS.

Conclusions: We developed a machine learning model that predicts postoperative length of stay with an error range of 2-4 days using admission data. This proof-of-concept study demonstrates the feasibility of predicting length of stay from admission data, showing that explainable AI can replicate intuitive patterns in surgical oncology while simultaneously identifying unexpected insights from administrative data. These findings highlight the clinical potential of explainable AI for perioperative workflow optimization.

背景:胃癌仍然是癌症相关发病和死亡的主要原因。尽管外科和围手术期护理取得了进展,但长期住院治疗继续给医疗保健系统带来压力。预测术后住院时间(LOS)可以支持个性化护理和有效的资源分配。日本全国范围的诊断程序组合(DPC)数据库为大规模分析提供了真实世界的数据,但没有研究应用机器学习来预测胃切除术后的LOS。方法:本回顾性研究包括2017年至2022年期间在日本472家医院接受胃切除术的26,097例患者。使用XGBoost,我们基于从DPC数据库中提取的1,433个准入时间变量开发了一个预测模型。在五重交叉验证中,使用均方根误差(RMSE)和平均绝对误差(MAE)来评估模型的性能。SHAP值用于解释特征的重要性。结果:最终模型RMSE为3.74,MAE为2.82天。LOS的主要预测因素包括手术方式(腹腔镜下远端胃切除术和开放式全胃切除术)、指定肿瘤医院、医院规模、腹膜扩散和入院ADL评分。SHAP分析显示,腹腔镜下远端胃切除术和更高的医院容积与较短的LOS相关,而开放式全胃切除术与较长的LOS相关。结论:我们开发了一种机器学习模型,利用入院数据预测术后住院时间,误差范围为2-4天。这项概念验证研究证明了从入院数据中预测住院时间的可行性,表明可解释的人工智能可以复制外科肿瘤学的直觉模式,同时从行政数据中识别意想不到的见解。这些发现强调了可解释的人工智能在围手术期工作流程优化中的临床潜力。
{"title":"Explainable machine learning for predicting postoperative length of stay after gastrectomy: a nationwide study using XGBoost and SHAP.","authors":"Tsunehiko Maruyama, Kazuto Ikezawa, Hideo Suzuki, Tomohiro Kurokawa, Yoshimasa Akashi, Tatsuya Oda","doi":"10.3389/fmedt.2025.1732580","DOIUrl":"10.3389/fmedt.2025.1732580","url":null,"abstract":"<p><strong>Background: </strong>Gastric cancer remains a major cause of cancer-related morbidity and mortality. Despite advances in surgical and perioperative care, prolonged hospitalization continues to strain healthcare systems. Predicting postoperative length of stay (LOS) could support personalized care and efficient resource allocation. Japan's nationwide Diagnosis Procedure Combination (DPC) database provides real-world data for large-scale analysis, but no study has applied machine learning to predict LOS after gastrectomy.</p><p><strong>Methods: </strong>This retrospective study included 26,097 patients who underwent gastrectomy between 2017 and 2022 at 472 hospitals in Japan. Using XGBoost, we developed a predictive model based on 1,433 admission-time variables extracted from the DPC database. Model performance was evaluated using Root Mean Squared Error (RMSE) and Mean Absolute Error (MAE) in a five-fold cross-validation. SHAP values were used to interpret feature importance.</p><p><strong>Results: </strong>The final model achieved an RMSE of 3.74 and MAE of 2.82 days. Key predictors of LOS included surgical procedure (laparoscopic distal gastrectomy and open total gastrectomy), designated cancer hospital, hospital size, peritoneal dissemination, and admission ADL score. SHAP analysis revealed that Laparoscopic distal gastrectomy and higher hospital volume were associated with shorter LOS, while open total gastrectomy was associated with longer LOS.</p><p><strong>Conclusions: </strong>We developed a machine learning model that predicts postoperative length of stay with an error range of 2-4 days using admission data. This proof-of-concept study demonstrates the feasibility of predicting length of stay from admission data, showing that explainable AI can replicate intuitive patterns in surgical oncology while simultaneously identifying unexpected insights from administrative data. These findings highlight the clinical potential of explainable AI for perioperative workflow optimization.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1732580"},"PeriodicalIF":3.8,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12714947/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145807069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An advanced multimodal image fusion model for accurate detection of Alzheimer's disease using MRI and PET. 一种先进的多模态图像融合模型,用于使用MRI和PET准确检测阿尔茨海默病。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-12-02 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1699821
Arshiya S Ansari, Mohammad Sajid Mohammadi, Carlo Cattani, Asifa Tassaddiq

The accurate detection of Alzheimer's disease (AD), a progressive and irreversible neurodegenerative disorder, remains a critical challenge in clinical neuroscience. The research aims to develop an advanced multimodal image fusion model for the accurate detection of AD using positron emission tomography (PET) and magnetic resonance imaging (MRI) techniques. The proposed method leverages structural MRI and functional 18-fluorodeoxyglucose PET (FDG-PET) information derived from the Alzheimer's Disease Neuroimaging Initiative (ADNI). After preprocessing, including Gaussian filtering, skull stripping, and intensity normalization, voxel-based morphometry (VBM) is applied to extract gray matter (GM) features relevant to AD progression. A GM mask generated from MRI is used to isolate corresponding metabolic activity in the PET scans. These features are then integrated using a mask-coding strategy to construct a unified representation that captures both anatomical and functional characteristics. For classification, the model introduces a Glowworm Swarm-Optimized Spatial Multimodal Attention-Enriched Convolutional Neural Network (GWS-SMAtt-ECNN), where the optimization enhances both feature selection and network parameter tuning. The Python was implemented, and the result demonstrates that the proposed multimodal image fusion strategy outperforms traditional unimodal and basic fusion approaches in terms of F1-score (94.22%), recall (96.73%), and accuracy (98.70%). These results highlight the therapeutic usefulness of the suggested improved fusion architecture in facilitating immediate and accurate AD detection by MRI and PET.

阿尔茨海默病(AD)是一种进行性和不可逆的神经退行性疾病,准确检测仍然是临床神经科学的一个关键挑战。该研究旨在开发一种先进的多模态图像融合模型,用于使用正电子发射断层扫描(PET)和磁共振成像(MRI)技术精确检测AD。该方法利用了来自阿尔茨海默病神经影像学倡议(ADNI)的结构MRI和功能性18-氟脱氧葡萄糖PET (FDG-PET)信息。在经过高斯滤波、颅骨剥离和强度归一化等预处理后,应用基于体素的形态学(VBM)提取与AD进展相关的灰质(GM)特征。MRI生成的GM掩膜用于分离PET扫描中相应的代谢活动。然后使用掩码编码策略集成这些特征,以构建捕获解剖和功能特征的统一表示。在分类方面,该模型引入了一种萤火虫群优化的空间多模态注意力富集卷积神经网络(gws - smart - ecnn),该网络的优化增强了特征选择和网络参数调整。结果表明,多模态图像融合策略在f1得分(94.22%)、召回率(96.73%)和准确率(98.70%)方面均优于传统的单模态和基本融合方法。这些结果强调了所建议的改进融合结构在促进MRI和PET快速准确检测AD方面的治疗价值。
{"title":"An advanced multimodal image fusion model for accurate detection of Alzheimer's disease using MRI and PET.","authors":"Arshiya S Ansari, Mohammad Sajid Mohammadi, Carlo Cattani, Asifa Tassaddiq","doi":"10.3389/fmedt.2025.1699821","DOIUrl":"10.3389/fmedt.2025.1699821","url":null,"abstract":"<p><p>The accurate detection of Alzheimer's disease (AD), a progressive and irreversible neurodegenerative disorder, remains a critical challenge in clinical neuroscience. The research aims to develop an advanced multimodal image fusion model for the accurate detection of AD using positron emission tomography (PET) and magnetic resonance imaging (MRI) techniques. The proposed method leverages structural MRI and functional 18-fluorodeoxyglucose PET (FDG-PET) information derived from the Alzheimer's Disease Neuroimaging Initiative (ADNI). After preprocessing, including Gaussian filtering, skull stripping, and intensity normalization, voxel-based morphometry (VBM) is applied to extract gray matter (GM) features relevant to AD progression. A GM mask generated from MRI is used to isolate corresponding metabolic activity in the PET scans. These features are then integrated using a mask-coding strategy to construct a unified representation that captures both anatomical and functional characteristics. For classification, the model introduces a Glowworm Swarm-Optimized Spatial Multimodal Attention-Enriched Convolutional Neural Network (GWS-SMAtt-ECNN), where the optimization enhances both feature selection and network parameter tuning. The Python was implemented, and the result demonstrates that the proposed multimodal image fusion strategy outperforms traditional unimodal and basic fusion approaches in terms of F1-score (94.22%), recall (96.73%), and accuracy (98.70%). These results highlight the therapeutic usefulness of the suggested improved fusion architecture in facilitating immediate and accurate AD detection by MRI and PET.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1699821"},"PeriodicalIF":3.8,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12705568/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145777045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging drug delivery approach using nanomaterials for the treatment of endometrial cancer. 使用纳米材料治疗子宫内膜癌的新兴药物递送方法。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-28 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1680519
Zhuorong Miao, Xiaoyan Xiong, Jiahong Gao, Yubing Hu, Dongdong Jin, Guiyuan Yu, Ping Jin, Wenjun Chen

Endometrial cancer, accounting for over 90% of uterine malignancies, has experienced a significant global rise in incidence and mortality. Conventional therapies face limitations including fertility compromise, systemic toxicity, drug resistance, and poor outcomes in advanced/recurrent cases. Considering the unique physical and chemical properties of nanomaterials, the emerging drug delivery approaches based on nanomaterials are regarded as a promising pathway for enhanced therapeutic efficiency to combat endometrial cancer. Herein, this mini-review discusses emerging drug delivery approaches to overcome current treatment challenges. We classify common therapeutic nanomaterials into polymer-based nanocarriers, quantum dots, liposomes, and exosomes, analyzing their synthesis, mechanisms, and preclinical efficacy. Finally, scientific challenges and future perspectives for ongoing research in this field are presented.

子宫内膜癌占子宫恶性肿瘤的90%以上,其发病率和死亡率在全球范围内显著上升。传统疗法面临着生育能力降低、全身毒性、耐药性以及晚期/复发病例预后差等局限性。考虑到纳米材料独特的物理和化学性质,新兴的基于纳米材料的给药方法被认为是提高子宫内膜癌治疗效率的有希望的途径。在此,这篇小型综述讨论了克服当前治疗挑战的新兴药物递送方法。我们将常见的治疗性纳米材料分为聚合物基纳米载体、量子点、脂质体和外泌体,分析了它们的合成、机制和临床前疗效。最后,对该领域正在进行的研究提出了科学挑战和未来展望。
{"title":"Emerging drug delivery approach using nanomaterials for the treatment of endometrial cancer.","authors":"Zhuorong Miao, Xiaoyan Xiong, Jiahong Gao, Yubing Hu, Dongdong Jin, Guiyuan Yu, Ping Jin, Wenjun Chen","doi":"10.3389/fmedt.2025.1680519","DOIUrl":"10.3389/fmedt.2025.1680519","url":null,"abstract":"<p><p>Endometrial cancer, accounting for over 90% of uterine malignancies, has experienced a significant global rise in incidence and mortality. Conventional therapies face limitations including fertility compromise, systemic toxicity, drug resistance, and poor outcomes in advanced/recurrent cases. Considering the unique physical and chemical properties of nanomaterials, the emerging drug delivery approaches based on nanomaterials are regarded as a promising pathway for enhanced therapeutic efficiency to combat endometrial cancer. Herein, this mini-review discusses emerging drug delivery approaches to overcome current treatment challenges. We classify common therapeutic nanomaterials into polymer-based nanocarriers, quantum dots, liposomes, and exosomes, analyzing their synthesis, mechanisms, and preclinical efficacy. Finally, scientific challenges and future perspectives for ongoing research in this field are presented.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1680519"},"PeriodicalIF":3.8,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12698538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Microbiome-based therapeutics for metabolic disorders: harnessing microbial intrusions for treatment. 更正:基于微生物组的代谢紊乱疗法:利用微生物侵入进行治疗。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-28 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1736962
Nafees Ahmed, Vishwas Gaur, Madhu Kamle, Abhishek Chauhan, Ritu Chauhan, Pradeep Kumar, Namita Ashish Singh

[This corrects the article DOI: 10.3389/fmedt.2025.1695329.].

[这更正了文章DOI: 10.3389/fmedt.2025.1695329.]。
{"title":"Correction: Microbiome-based therapeutics for metabolic disorders: harnessing microbial intrusions for treatment.","authors":"Nafees Ahmed, Vishwas Gaur, Madhu Kamle, Abhishek Chauhan, Ritu Chauhan, Pradeep Kumar, Namita Ashish Singh","doi":"10.3389/fmedt.2025.1736962","DOIUrl":"https://doi.org/10.3389/fmedt.2025.1736962","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/fmedt.2025.1695329.].</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1736962"},"PeriodicalIF":3.8,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12699589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Explainable multi-modal machine learning for predicting occult pulmonary metastases in differentiated thyroid cancer: a SHAP-based approach prior to radioactive iodine scans. 可解释的多模态机器学习用于预测分化甲状腺癌的隐性肺转移:放射性碘扫描前基于shap的方法。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-11-28 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1685088
Yuqi Su, Yuhuang Cai, Shui Jin, Xuemei Ye, Jaesik Jeong, Ye Yuan, Heqing Yi

Background: Patients with differentiated thyroid cancer (DTC) may have occult lung metastases before 131iodine (131I) treatment. Identifying occult lung metastases before 131I treatment is of great clinical value for the correct staging of patients and the establishment of 131I treatment plans. Our research is of great significance in establishing statistical models for clinical data using machine learning algorithms to study the prediction of lung metastasis before 131I treatment.

Methods: Patients were selected from Zhejiang cancer hospital and data was from two groups of DTC patients treated with 131I, where the experimental group consisted of 55 patients who showed no lung metastases on CT but tested positive on 131I-whole body scan (131I-WBS). The control group included 316 patients who tested negative for metastases across CT, ultrasound, and 131I-WBS. Six machine learning algorithms such as Support Vector Machines (SVM), Decision Trees (DT), Random Forests (RF), Logistic Regression (LR), Extreme Gradient Boosting (XGBoost), and K-Nearest Neighbors (KNN) were employed to predict models and AUC, sensitivity, accuracy, precision, specificity, F1 Score were used to compare the performance between each models. Finally, the SHAP algorithm was used to explain the importance rank of the features.

Results: A total of 371 thyroid cancer patients were included in this study, 55 patients with occult lung metastasis and 316 patients in the control group. The data is divided into a training set and a testing set in a 7:3 ratio. Eleven acceptable variables analyzed including gender, age, T stage, N stage, tumor size, degree of invasion, number of lymph node metastases count, Thyroid Stimulating Hormone (TSH), thyroglobulin (Tg), Thyroglobulin antibodies (Tgab), and administrated activity were screened out by multivariate Cox regression. Evaluation indicators of the best model- LR were as following: accuracy (0.91), recall rate (0.64), precision (0.92), F1-s core (0.70), Area Under Curve (AUC) value (0.93), and the Specificity score (0.96).

Conclusion: The logistic model (LR) showed the best performance in predicting occult lung metastases of thyroid cancer patients before 131I-WBS. Lymph nodes metastases and throglobulin have the most significant impact on the prediction.

背景:分化型甲状腺癌(DTC)患者在131碘(131I)治疗前可能有隐匿性肺转移。在131I治疗前鉴别肺隐匿性转移灶,对患者正确分期及制定131I治疗方案具有重要的临床价值。我们的研究对于利用机器学习算法建立临床数据统计模型,研究131I治疗前肺转移的预测具有重要意义。方法:选取浙江省肿瘤医院的患者,数据来自两组经131I治疗的DTC患者,其中实验组55例CT未见肺转移,131I-全身扫描(131I- wbs)阳性。对照组包括316例通过CT、超声和131I-WBS检测为转移阴性的患者。采用支持向量机(SVM)、决策树(DT)、随机森林(RF)、逻辑回归(LR)、极限梯度增强(XGBoost)和k近邻(KNN)等6种机器学习算法预测模型和AUC、灵敏度、准确度、精密度、特异性和F1评分来比较各模型的性能。最后,利用SHAP算法对特征的重要性排序进行解释。结果:本研究共纳入371例甲状腺癌患者,其中隐匿性肺转移55例,对照组316例。数据按7:3的比例分为训练集和测试集。通过多变量Cox回归筛选出11个可接受的变量,包括性别、年龄、T分期、N分期、肿瘤大小、侵袭程度、淋巴结转移数、促甲状腺激素(TSH)、甲状腺球蛋白(Tg)、甲状腺球蛋白抗体(Tgab)和给药活性。最佳模型LR的评价指标为:准确率(0.91)、召回率(0.64)、精密度(0.92)、F1-s核心(0.70)、曲线下面积(AUC)值(0.93)、特异性评分(0.96)。结论:logistic模型(LR)对131I-WBS前甲状腺癌患者隐匿性肺转移的预测效果最好。淋巴结转移和凝球蛋白对预测影响最大。
{"title":"Explainable multi-modal machine learning for predicting occult pulmonary metastases in differentiated thyroid cancer: a SHAP-based approach prior to radioactive iodine scans.","authors":"Yuqi Su, Yuhuang Cai, Shui Jin, Xuemei Ye, Jaesik Jeong, Ye Yuan, Heqing Yi","doi":"10.3389/fmedt.2025.1685088","DOIUrl":"10.3389/fmedt.2025.1685088","url":null,"abstract":"<p><strong>Background: </strong>Patients with differentiated thyroid cancer (DTC) may have occult lung metastases before <sup>131</sup>iodine (<sup>131</sup>I) treatment. Identifying occult lung metastases before <sup>131</sup>I treatment is of great clinical value for the correct staging of patients and the establishment of <sup>131</sup>I treatment plans. Our research is of great significance in establishing statistical models for clinical data using machine learning algorithms to study the prediction of lung metastasis before <sup>131</sup>I treatment.</p><p><strong>Methods: </strong>Patients were selected from Zhejiang cancer hospital and data was from two groups of DTC patients treated with <sup>131</sup>I, where the experimental group consisted of 55 patients who showed no lung metastases on CT but tested positive on <sup>131</sup>I-whole body scan (<sup>131</sup>I-WBS). The control group included 316 patients who tested negative for metastases across CT, ultrasound, and <sup>131</sup>I-WBS. Six machine learning algorithms such as Support Vector Machines (SVM), Decision Trees (DT), Random Forests (RF), Logistic Regression (LR), Extreme Gradient Boosting (XGBoost), and K-Nearest Neighbors (KNN) were employed to predict models and AUC, sensitivity, accuracy, precision, specificity, F1 Score were used to compare the performance between each models. Finally, the SHAP algorithm was used to explain the importance rank of the features.</p><p><strong>Results: </strong>A total of 371 thyroid cancer patients were included in this study, 55 patients with occult lung metastasis and 316 patients in the control group. The data is divided into a training set and a testing set in a 7:3 ratio. Eleven acceptable variables analyzed including gender, age, T stage, N stage, tumor size, degree of invasion, number of lymph node metastases count, Thyroid Stimulating Hormone (TSH), thyroglobulin (Tg), Thyroglobulin antibodies (Tgab), and administrated activity were screened out by multivariate Cox regression. Evaluation indicators of the best model- LR were as following: accuracy (0.91), recall rate (0.64), precision (0.92), F1-s core (0.70), Area Under Curve (AUC) value (0.93), and the Specificity score (0.96).</p><p><strong>Conclusion: </strong>The logistic model (LR) showed the best performance in predicting occult lung metastases of thyroid cancer patients before <sup>131</sup>I-WBS. Lymph nodes metastases and throglobulin have the most significant impact on the prediction.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1685088"},"PeriodicalIF":3.8,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12698535/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in medical technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1